Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tekla Life Sciences Investors
HQLCurrent price
14.65 USD
+0.12 USD (+0.83%)
Last closed
14.56 USD
Company
www.teklacap.com
ISIN
US87911K1007
Sector
Financial Services
Industry
Asset Management
Exchange
NYSE
Capitalization
408 343 136 USD
Yield for 12 month
+18.15 %
1Y
3Y
5Y
10Y
15Y
HQL
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. Address: 1900 Market Street, Philadelphia, PA, United States, 19103
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
11.1269Dividend Yield
13.38 %Current Year
+23 523 699 USD
Last Year
-103 250 433 USD
Current Quarter
+1 032 632 USD
Last Quarter
+1 032 632 USD
Current Year
+23 523 699 USD
Last Year
-103 250 433 USD
Current Quarter
-1 498 947 USD
Last Quarter
+1 032 632 USD
Key Figures HQL
1 year
3 years
5 years
10 years
EBITDA
–
Operating Margin TTM
PE Ratio
11.1269
Return On Assets TTM
-0.32 %
PEG Ratio
–
Return On Equity TTM
1.28 %
Wall Street Target Price
–
Revenue TTM
3 512 919 USD
Book Value
16.13 USD
Revenue Per Share TTM
Dividend Share
1.3 USD
Quarterly Revenue Growth YOY
7 %
Dividend Yield
13.38 %
Gross Profit TTM
3 018 956 USD
Earnings per share
1.34 USD
Diluted Eps TTM
1.34 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
42.5 %
Profit Margin
156.45 %
Dividend Analytics HQL
Dividend growth over 5 years
-22 %Continuous growth
1 yearPayout Ratio 5 years average
34 %Dividend History HQL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
1.96
Ex Dividend Date
23.08.2024
Forward Annual Dividend Yield
13.15 %
Last Split Factor
–
Payout Ratio
99.25 %
Last Split Date
–
Dividend Date
31.12.2018
Stock Valuation HQL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
11.1269
Forward PE
–
Enterprise Value Revenue
10.2075
Price Sales TTM
116.2404
Enterprise Value EBITDA
–
Price Book MRQ
0.9246
Financials HQL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HQL
For 52 weeks
10.17 USD
15.68 USD
50 Day MA
15.14 USD
Shares Short Prior Month
154 069
200 Day MA
14.25 USD
Short Ratio
0.74
Shares Short
62 302
Short Percent
–
BeatStart